A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients.
- DOI
- 10.1182/bloodadvances.2026021068
- Published
- 2026 Sep 16
- Container
- Blood advances
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2026021068,
title = {A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients.},
author = {Skorupski C and Chodirker L and Mozessohn L and England JT and Kennedy JA and Cheung MC and Chow S and Teichman J and Goldberg N and Hershenfeld SA and Tsui H and Mamedov A and Siddiqui M and Zhang L and Buckstein RJ},
year = {2026},
journal = {Blood advances},
doi = {10.1182/bloodadvances.2026021068},
url = {https://doi.org/10.1182/bloodadvances.2026021068}
}RIS
TY - JOUR TI - A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients. AU - Skorupski C AU - Chodirker L AU - Mozessohn L AU - England JT AU - Kennedy JA AU - Cheung MC AU - Chow S AU - Teichman J AU - Goldberg N AU - Hershenfeld SA AU - Tsui H AU - Mamedov A AU - Siddiqui M AU - Zhang L AU - Buckstein RJ PY - 2026 JO - Blood advances DO - 10.1182/bloodadvances.2026021068 UR - https://doi.org/10.1182/bloodadvances.2026021068 ER -
APA
C, S., L, C., L, M., JT, E., JA, K., MC, C., S, C., J, T., N, G., SA, H., H, T., A, M., M, S., L, Z., & RJ, B. (2026). A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients.. Blood advances. https://doi.org/10.1182/bloodadvances.2026021068
Source records
- pubmed · retrieved 2026-09-26T08:55:17.987Z
- europe-pmc · retrieved 2026-09-26T08:55:17.999Z